Related Experiment Video

Updated: May 22, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Ventilator-associated pneumonia: a comprehensive review

Jean-Louis Trouillet1

  • 1Service de Réanimation Médicale, Institut de Cardiologie, Groupe Hospitalier Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine Paris 6-Pierre et Marie Curie, Paris, France. jean-louis.trouillet@psl.aphp.fr.

Hospital Practice (1995)
|May 23, 2012
PubMed

Insights

Ventilator-associated pneumonia (VAP) is a common and serious intensive care unit infection. This review covers VAP

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Ventilator-associated pneumonia (VAP) is the most frequent severe infection in the intensive care unit (ICU).
  • VAP is associated with prolonged mechanical ventilation and increased mortality.
  • Despite its significance, several aspects of VAP remain controversial.

Purpose of the Study:

  • To provide a comprehensive review of ventilator-associated pneumonia (VAP).
  • To discuss risk factors, causative agents, diagnosis, treatment, and prevention strategies for VAP.
  • To highlight controversial areas in VAP management.

Main Methods:

  • Literature review of VAP.
  • Synthesis of current knowledge on VAP epidemiology, pathogenesis, and clinical management.
  • Identification of areas requiring further research.

Main Results:

  • VAP presents significant challenges in diagnosis and management.
  • Multiple factors contribute to VAP development.
  • Effective prevention strategies are crucial but debated.
  • Treatment approaches vary, with ongoing controversies.

Conclusions:

  • VAP requires a multifaceted approach involving prevention, early diagnosis, and appropriate treatment.
  • Further research is needed to resolve controversial aspects of VAP management.
  • Optimizing VAP care is essential for improving patient outcomes in the ICU.

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: